Alcohol Addiction – Pipeline Review, 2024

Alcohol Addiction is the inability to manage alcohol drinking habits. An uncontrolled urge to drink, lack of control on alcohol consumption and psychological effects of alcohol are certain symptoms of alcohol addiction. According to data published by American Addiction Centre in 2018, an estimated 7.0% of the adult U.S. population was affected by alcohol addiction. Mild, moderate and severe are the types of alcohol addiction. Alcohol addiction may lead to liver cancer, mouth cancer, and other physiological damages.

Currently, there are various drugs available for the treatment of alcohol addiction, which includes, Acamprosate, Naltrexone, Vivitrol, Disulfiram, and others. Out of these drugs, Acamprosate and Naltrexone have a psychological effect on patients as they reduce alcohol cravings and urge. Combined with drug treatment, Cognitive Behavioural Therapy is also extensively utilized to treat the patient who is addicted to alcohol. 

 Academic centers and research institutes have focussed on studying and developing new methods for the treatment of alcohol addiction. For instance; Mifepristone, which is being studied by The Scripps Research Institute, is currently in phase-2 clinical trials for the study with the aim to validate the efficacy of the drug for the treatment of alcohol use disorder.

To know how our report can help streamline your business, Speak to Analyst

At present more than 50% of the pipeline candidates for Alcohol Addiction are in the phase-2 and phase-3 stage. Majority of the studies have been sponsored by academic centers and research institutes.

Report Description

The report on ‘Alcohol Addiction – Pipeline Review, 2024’ provides a comprehensive overview of the drugs that are in the R&D pipeline by indication or molecule for Alcohol Addiction. The report provides a thorough analysis of the distribution of the pipeline products by clinical trial stage, indication, company, therapy area and details such as clinical trial stage, sponsor, description on every product in the pipeline. Products in the preclinical and clinical stage along with dormant & discontinued pipeline candidates are included in the report. The report also covers additional insights such as epidemiology overview and current market scenario for Alcohol Addiction.

The report on ‘Alcohol Addiction – Pipeline Review, 2024’, which is built by following a robust research methodology involving primary interviews and desk research, provides a complete overview of the R&D activity and pipeline products to assist companies in developing growth strategies and identifying emerging players.

Report Scope

• Thorough assessment of the pipeline products by areas such as development stage; route of administration; drug class; indication; sponsor; molecule type and drug target
• Comprehensive profiles of the pipeline products with details such as company overview; product description; R&D status; development activities; mechanism of action; molecule type; development stage; indications; funding and route of administration
• Overview of dormant and discontinued pipeline products
• Key insights in relation to the epidemiology of conditions being treated by the pipeline products and overview of the addressable or current market for the pipeline products
• Overview of the latest developments; news articles, press releases and relevant conferences

Report Methodology

• All pipeline reports are built through the analysis of data primarily collected through credible desk research sources. Secondary research is supplemented by interviews conducted with key opinion leaders.
• Desk research sources includes global and regional clinical trials databases; annual reports, websites, press releases & investor presentations of companies; white papers; news articles; reports published by industry associations; articles/reports published on databases such as NCBI, ResearchGate; internal databases

Reasons to Buy this Report

• Develop effective growth strategies based on comprehensive overview of the R&D activity and pipeline products for Alcohol Addiction
• Identify emerging players or competition in the market based on pipeline products and develop strategies to counter the emergence of these players
• Identify the focus of leading players in relation to R&D for Alcohol Addiction
• Identify potential companies from a partnership or acquisition point of view based on current synergy in R&D activities or strategies to diversify R&D focus to drive growth in business
• Analyse the reasons behind dormant and discontinued products to make changes in the R&D focus if necessary